Skip to main content


Table 1 Serological analysis of CMV, EBV and HHV-8 antibodies over time

From: Fulminant anaplastic large cell lymphoma (ALCL) concomitant with primary cytomegalovirus (CMV) infection, and human herpes virus 8 (HHV-8) infection together with Epstein-Barr-virus (EBV) reactivation in a patient with asymptomatic HIV-infection

Test used 9 months prior to admission Day 3 Day 10 Day 21
CMV IgG EIA <100a < 100a 500b 1000b
CMV-IgM capture EIA <100a < 100a 100b Close to cut-offa
EBV-EIA (EBNA) IgG > = 20b > = 20b   > = 20b
EBV-IgG VCA EIA, U/mL 75b 120b   130b
EBV-IgM EIA Negative Negative   <= 40a
HHV-8 IFT (lytic antigens) Negative Positive   Positive
HHV-8 LANA (latent nuclear antigens) Negative Negative   Negative
  1. EIA enzyme immunosorbent assay, VCA viral capsid antigen
  2. anegative
  3. bpositive